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ERK2 Suppresses Self-Renewal Capacity of Embryonic
Stem Cells, but Is Not Required for Multi-Lineage
Commitment
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Abstract
Activation of the FGF-ERK pathway is necessary for naı¨ve mouse embryonic stem (ES) cells to exit self-renewal and commit
to early differentiated lineages. Here we show that genetic ablation of Erk2, the predominant ERK isozyme expressed in ES
cells, results in hyper-phosphorylation of ERK1, but an overall decrease in total ERK activity as judged by substrate
phosphorylation and immediate-early gene (IEG) induction. Normal induction of this subset of canonical ERK targets, as well
as p90RSK phosphorylation, was rescued by transgenic expression of either ERK1 or ERK2 indicating a degree of functional
redundancy. In contrast to previously published work, Erk2-null ES cells exhibited no detectable defect in lineage
specification to any of the three germ layers when induced to differentiate in either embryoid bodies or in defined neural
induction conditions. However, under self-renewing conditions Erk2-null ES cells express increased levels of the
pluripotency-associated transcripts, Nanog and Tbx3, a decrease in Nanog-GFP heterogeneity, and exhibit enhanced self-
renewal in colony forming assays. Transgenic add-back of ERK2 is capable of restoring normal pluripotent gene expression
and self-renewal capacity. We show that ERK2 contributes to the destabilization of ES cell self-renewal by reducing
expression of pluripotency genes, such as Nanog, but is not specifically required for the early stages of germ layer
specification.
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Introduction
Pluripotent mouse embryonic stem (ES) cells are immortal,
karyotypically stable, cell lines derived from the inner cell mass
(ICM) or early epiblast of pre-implantation embryos [1–3]. They
maintain many of the characteristics of their in vivo counterparts
even after prolonged periods of culture, not least of which is the
ability to generate differentiated cell types of all three germ layers
as well as contribute to the germ line [4]. The efficient derivation
and maintenance of ES cells is heavily dependent on genetic
background [5,6], and supported by the combined activities of
leukemia inhibitory factor (LIF) and bone morphogenetic protein
(BMP) signaling [7]. Both genetic studies [8,9] and whole
transcriptome analysis [10] have provided a wealth of information
as to the factors that maintain ES cells in an undifferentiated state,
and the signaling networks that regulate their expression [11]. Our
current understanding is that the combined activities of a core
network consisting of the transcription factors OCT4, SOX2 and
Nanog act to maintain ES cell identity by inhibiting the expression
of lineage affiliated genes [12] and supporting a pluripotent
epigenetic signature [10].
Although much is now known about the molecular require-
ments for efficient ES cell self-renewal, the means by which cells
exit this state and acquire the competence to respond to
differentiation cues is less well understood. Genetic studies have
shown that fibroblast growth factor (FGF) signaling through
GRB2-RAS is essential for peri-implantation mouse embryogen-
esis and the formation of the primitive endoderm lineage [13–16].
The ES cell, and presumably ICM/epiblast expression of Fgf4 is
driven by a ternary complex consisting of OCT4, SOX2 and the
Fgf4 distal enhancer [17], and acts as a major auto-inductive cue
for ES cell differentiation, but is largely dispensable for prolifer-
ation [18,19]. Moreover, it has been shown that the combined
pharmacological inhibition of FGF-ERK and glycogen synthase
kinase 3 (GSK3) signaling pathways promotes long-term self-
renewal of ES cells in the absence of both LIF and BMP4 [7]. This
dual inhibitor (2i) culture condition permitted the derivation of ES
cell lines from previously refractory genetic backgrounds such as
CBA [5], and non-obese diabetic (NOD) mice [20], and
importantly the establishment of authentic rat ES cells [21,22].
Because ERK2 is the predominant ERK enzyme expressed in
ES cells, and because of its early embryonic phenotype [23,24], we
sought to determine the effect of Erk2 genetic ablation on FGF
signaling, self-renewal and lineage specification. Here we present
evidence that ERK2 is necessary for maximal FGF-ERK signaling
and its deletion results in a modest, but consistent increase in self-
renewal capacity and reduction in heterogeneity of Nanog
expression in self-renewing culture conditions. In contrast to our
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previous work which indicated a requirement for ERK2 in both
neural and mesodermal specification [18], we found that our new
Erk22/2 ES cells did not exhibit any significant defects in germ
layer specification when induced to differentiate. Either ERK1 or
ERK2 could rescue the FGF signaling defects in Erk22/2 cells
suggesting these enzymes share some functional redundancy in
mouse ES cells. We propose that total combined ERK activity
impacts on ES cell self-renewal by reducing pluripotent gene
expression and that ERK1 and ERK2 share overlapping functions
during the earliest stages of ES cell differentiation.
Results
Targeting Erk2 in Mouse ES Cells
To disrupt Erk2 function, germ-line competent 129/Ola ES
cells (E14Ju) were depleted for exon 3 of the Erk2 gene by two
round of homologous recombination (Figure 1A). This strategy
removes the region coding for kinase sub-domains V and VI,
essential for ERK2 function, and has been previously shown to
create a protein-null Erk2 allele [23,25]. Heterozygous ES cell
clones were first screened for reduction of exon 3 alleles by
quantitative PCR (qPCR) and putative targeted lines were
confirmed by Southern blotting (Figure 1B). Two heterozygous
Erk2+/2 ES cell clones (D2 and D7) were subjected to a second
round of homologous recombination and clones were first
screened for complete loss of exon 3 by qPCR, and further
confirmed by Southern blotting (Figure 1C). All clones were
karyotyped following clonal expansion and retained normal ploidy
(Figure S1). Two Erk2-null clones, D7N2 and D2N4, each derived
from independent heterozygous clones, D7 and D2, respectively,
were selected for further analysis.
To test whether the targeted mutation generated the predicted
null allele, Erk2 expression was assessed by qRT-PCR and ERK2
protein by western blotting. A 50% reduction of Erk2 expression
was observed in heterozygous Erk2+/2 ES cells, and an absence of
mRNA from both homozygous null lines (Figure 2A). Moreover,
there was no evidence of a compensatory increase in Erk1 mRNA
expression. This was also confirmed on the protein level by
immunoblotting with a polyclonal antibody that recognizes both
ERK1 and ERK2 (Figure 2B).
ERK2 Depletion Attenuates Short Term, but not Long
Term FGF-ERK Signaling
To test whether ERK signaling was perturbed in the absence of
ERK2, lysates from WT and Erk22/2 ES cells, as well as Erk22/2
cells expressing FLAG-ERK2 from a randomly integrated
transgene were examined for phosphorylation status of the
ERK, MEK, and p90RSK enzymes. In steady-state self-renewing
conditions ERK2 depletion resulted in a 3-fold increase in the
ratio of phospho-ERK to total ERK, which was returned to a
normal ratio in FLAG-ERK2 expressing cells (Figure 2C,D).
However, the amount of total phospho-ERK, i.e. pERK1(+-
pERK2)/GAPDH, was decreased by approximately 50% in
ERK2-deficient ES cells (Figure 2D). Moreover the decrease in
total phospho-ERK in Erk2 knock-out cells translated into a
similar decrease in phospho-p90RSK levels on the ERK-
dependent sites T358 and S362 (Figure 2E) [26]. Interestingly,
depletion of ERK2 resulted in an increase in the levels of phospho-
MEK1/2 (upstream ERK kinases) at S211 and S217 (Figure 2E),
suggesting that the observed increase in ERK1 phosphorylation in
Erk2-null ES cells was due to decreased ERK-dependent negative
feedback up-stream in the kinase cascade [27]. To examine FGF
responsiveness in the absence of ERK2 we inhibited endogenous
FGF signaling with a chemical inhibitor (PD173074) for 24 h
followed by a wash-out and stimulation with recombinant FGF2
for 5–120 min. This acute stimulation with FGF2 exhibited similar
time-to-peak (10–30 min) and decay kinetics in the presence or
absence of ERK2 (Figure 2F). However, the ERK2-deficient ES
cells exhibited a decrease in p90RSK phosphorylation indicating a
reduction in the overall output of ERK signaling (Figure 2F).
As both ERK1/2 and p90RSK activities have been shown to be
essential for the induction of immediate-early genes (IEGs) cFos,
Egr1, and Egr2 in other systems [28,29], we next asked if this global
reduction in ERK activity was reflected in the transcriptional
response to FGF stimulation. qRT-PCR analysis of IEGs Egr1 and
Egr2 expression following acute stimulation with FGF2 showed an
approximately 70% reduction in their induction at 1 hour post-
stimulation in ERK2-deficient ES cells consistent with a reduction
in FGF pathway activity (Figure 3A). The induction of another
IEG, cFos, was only reduced by approximately 35% in Erk22/2 ES
cells (Figure 3A). However, its induction was similar to FGF
stimulation of WT cells in the presence of the MEK inhibitor
PD0325901. This indicated that only a fraction of cFos induction
was MEK-dependent, with the MEK-independent cFos expression
possibly being due to FGF-mediated phosphatidylinositol 39-OH
kinase (PI3K)-AKT induction of cFos [30].
Dusp6 expression and its protein stability are both regulated by
ERK activity [31,32] where they act in a negative feedback loop
that regulates the duration of ERK activity [29]. As the duration of
ERK activity can determine the expression of late response genes
[33], we asked if the expression of Dusp6 was attenuated in the
absence of ERK2 and if this correlated with a difference in late
response gene expression such as D-type cyclins. Similar to Egr1,
Egr2, and cFos, the magnitude of Dusp6 expression was reduced in
Erk22/2 ES cells (Figure 3B), however FGF2-induced, MEK-
dependent, Ccnd2 expression was not affected by loss of ERK2
(Figure 3C) indicating that the initial decrease in pathway activity
can be compensated for in the long term, possibly by a decreased
amount of induced negative feedback. Consistent with studies into
the unique cell cycle architecture of mouse ES cells [34], Ccnd3
expression was independent of both ERK and MEK activity
(Figure 3D).
To test whether the attenuation of IEG induction in Erk2-null
ES cells was isozyme specific, or a consequence of reduced total
ERK activity, ERK2 depletion was rescued by transgenic
expression of either 3xFLAG-ERK1 or 3xFLAG-ERK2. Western
blot analysis showed that both exogenous ERK1 and ERK2 were
expressed at comparable levels to endogenous ERK2 in WT cells,
and were phosphorylated normally following FGF2 stimulation
(Figure 4A). qRT-PCR analysis of IEG induction showed that
either ERK isozyme was equally capable of reinstating normal
levels of Egr1, Egr2 and cFos induction (Figure 4B) arguing that
ERK1 and ERK2 overlap functionally with respect to induction of
this subset of IEGs in mouse ES cells. We also examined the
activity of other signaling pathways and found that ERK2 deletion
does not perturb the stability of b-catenin nor the phosphorylation
status of STAT3, AKT, and SMAD2 in self-renewing ES cells
(Figure 4C).
ERK2 is Dispensable for Germ Layer Specification of ES
Cells
We have previously reported a block in both neural and
mesodermal differentiation in ERK2-deficient ES cells [18].
However, this block was not reversed upon transgenic rescue
(Figure S2A,B), even though exogenous ERK2 was phosphorylat-
ed normally and rescued the defect in Egr1 induction (Figure
S2C,D). Moreover, ERK2-deficient cells were capable of gener-
ating both endodermal and mesodermal cell types in embryoid
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bodies (Figure S2E). Therefore it is likely that the differentiation
defect exhibited by these ES cells is not related to the targeted
mutation at the Erk2 locus, and possibly related to genetic
background, since they were derived from a C57Bl/6–129 F1
cross [23], or to an unknown mutation during the derivation of
these ES cell lines from blastocysts. We therefore examined the
ability of new Erk22/2 ES cells generated on a pure 129
background to commit to various differentiated lineages. Embry-
oid body (EB) differentiation was employed as it produces
descendants of all three germ layers in 3-D culture, and is
therefore an unbiased reflection of the potency of mES cells in
culture. EBs produced from Erk22/2 ES cells exhibited similar
morphological features to parental E14Ju wild-type ES cells
(Figure 5A), with cystic EBs visible from day 6, and rhythmically
beating cardiomyocytes evident by day 8 (data not shown). A time
course of gene expression analysis showed no major differences in
the down-regulation of the pluripotency markers, Rex1 and Nanog,
or up-regulation of endodermal (Gata4, Foxa2) and mesodermal
markers (T, Acta2), indicating no general impairment in differen-
tiation (Figure 5B). However, ERK2-deficient ES cells expressed
Figure 1. Erk2 gene targeting. (A) Schematic illustrating the WT Erk2 locus, and both Dexon 3 (Hph and Neo) targeted alleles. Black bars indicate
the location of the 3’ probe used for Southern blotting. Sizes of the KpnI and KpnI-PstI fragments for the WT and targeted alleles, respectively, are
shown. Hph-TK: hygromycin B phosphotransferase-thymidine kinase fusion gene; Neor: neomycin resistance gene. (B) Correct targeting in
heterozygous ES cells was screened by genomic qPCR for loss of a single exon 3 allele (top), and confirmed by Southern blotting (bottom). (C) The
second targeting to generate homozygous Erk2-null ES cells was also screened by genomic qPCR (top), and confirmed by Southern blotting (bottom).
doi:10.1371/journal.pone.0060907.g001
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higher levels of Nanog in self-renewing conditions (Day 0), and a
more prominent induction of a-smooth muscle actin (Acta2)
expression at Day 6 and Gata4 at Day 4 (Figure 5B).
Next we specifically investigated the requirement of ERK2
during neural induction using an established monolayer differen-
tiation protocol in serum-free N2B27 medium [35], in which
embryo-derived Erk2 knock-out ES cells failed to form neural
tissue (Figure S2) [18]. Following 5 days of differentiation ES-
derived Erk2-null cells generated bIII tubulin-positive neurons
with similar efficiency to WT and heterozygous lines (Figure 6A).
qRT-PCR analysis showed almost complete down-regulation of
pluripotency markers (Oct4, Nanog, Rex1) in all cell lines by day 5 of
neural induction, with a concomitant increase in neural markers,
NeuroD3, Ngn2, and Mash1 (Figure 6B). As observed for the EB
experiments, the expression of Nanog was higher in Erk2-null ES
cells at Day 0 (Figure 6B), indicating that ES cells may self-renewal
more efficiently in the absence of ERK2.
Figure 2. ERK2 ablation attenuates FGF-ERK signaling. (A) qRT-PCR analysis showing reduced or absent Erk2 transcript in the mutated lines,
with no compensatory increase in Erk1 expression. (B) Western blot analysis of total ERK1/2 protein levels in WT, heterozygous, and homozygous Erk2
cell lines. ERK2 expression is reduced in the heterozygous line D2, and completely absent in the Erk22/2 lines D7N2 and D2N4. Tubulin is used as a
loading control. The qRT-PCR and western results for the heterozygous line D7 were identical to clone D2 (not shown). (C) Western blot analysis of
wild-type (E14Ju), Erk22/2, FLAG-ERK2-rescued Erk22/2 ES cells. The levels of phospho-ERK1/2, phospho-RSK and phospho-MEK1/2 were examined in
self-renewing culture conditions. (D) Quantification of western blotting data to examine the ratio of phosphorylated ERK1/2 to total ERK1/2 (left), and
pERK1/2 to GAPDH (right) in E14Ju, Erk22/2, and ERK2-rescued Erk22/2 lines. (E) Quantification of western blotting data to examine the ratio of
phosphor-RSK to GAPDH (left), and phospo-MEK1/2 to total MEK1/2 (right) in E1Ju, Erk22/2, and ERK2-rescued Erk22/2 lines. (F) Western blot analysis
of ERK1/2 and RSK activation in wild-type (E14Ju) and Erk22/2 ES cells following acute FGF2 stimulation. Phosphorylation of p90RSK is reduced in the
absence of ERK2. Membranes were stripped and sequentially blotted with the indicated antibodies.
doi:10.1371/journal.pone.0060907.g002
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ERK2 Suppresses Expression of a Subset of Pluripotent
Genes
To further investigate the elevated Nanog expression in ES cells
lacking ERK2, two independent Erk22/2 ES cell clones were
rescued with ERK2 expression constructs. Transgenic expression
of ERK2 was capable of reinstating normal levels of Nanog to
Erk22/2 ES cells (Figure 7A). A second elevated pluripotent
marker, Tbx3, was similarly increased in Erk22/2 ES cells and
rescued to wild-type levels by an ERK2 expression construct. A
similar, but less dramatic effect was also observed for Klf4
(Figure 7A). No significant difference was observed for Oct4 levels
across all cell lines tested. ERK2 deficiency had the most
significant effect on Tbx3 levels (a one-tailed t-test giving p-values
of 0.02 and 0.01 for D7N2 and D2N4, respectively). This is
consistent with previous reports that Tbx3 is a negatively regulated
direct target of ERK signaling in ES cells, and that TBX3 can
positively regulate Nanog promoter activity [11]. It is of note that
Nanog, Tbx3, Klf4 are expressed heterogeneously in self-renewing
ES cells [11] in contrast to the homogenous expression of Oct4,
which did not exhibit significant differences in expression in the
absence of ERK2. Therefore we hypothesized that ERK2
deficiency may reduce heterogeneity of self-renewing undifferen-
tiated ES cells. To test this hypothesis, an EGFP cassette was
knocked into the endogenous Nanog promoter in Erk22/2 ES cells
(Figure S3) [36]. Two correctly targeted clones, one each from
D7N2 and D2N4 Erk2-null lines, were stably transfected with an
ERK2 expression cassette and the extent of EGFP expression was
assessed by flow cytometry (Figure 7B). While the majority of Erk2-
null ES cells exhibited high Nanog-GFP expression, a significant
Nanog-GFP low subpopulation appeared when ERK2 was re-
introduced (Figure 7B). This is consistent with other reports which
show that Nanog heterogeneity is reduced in the presence of
chemical inhibitors of MEK-ERK signaling [36,37]. To further
examine this phenomenon for a different pluripotent gene, we
generated a Tcfcp2l1-Venus reporter construct and stably trans-
fected it into Erk22/2 and ERK2-rescued Erk22/2 ES cells (Figure
S4A). Tcfcp2l1 is a grainyhead transcription factor that is highly
expressed in mouse ES cells and rapidly down-regulated upon
differentiation [38], and it is a direct binding partner of OCT4
[39]. In self-renewing (+LIF) conditions 97% of Erk22/2 ES cells
were positive for the Tcfcp2l1-Venus reporter, but this was reduced
to 86% when ERK2 was added back to the cells (Figure S4B). The
kinetics of Tcfcp2l1-Venus reporter expression during differentia-
tion (removal of LIF) was examined for the Erk22/2 and ERK2-
rescued ES cells and both cell lines efficiently down-regulated this
reporter (Figure S4C). This result indicates that ERK2 plays a
major role to generate heterogeneous gene expression in self-
renewing ES cells, but has little impact on their down-regulation
during differentiation.
ERK2 Suppresses Self-renewal Capacity of ES Cells
To test if this reduced heterogeneity was functionally significant
the self-renewal capacity of ERK2-deficient ES cells was tested in
a stringent clonal density assay in the presence of LIF. Self-
renewing cells were identified by alkaline phosphatase activity after
7 days at clonal density [40]. Colonies were counted and scored
based on the degree of differentiation observed. In WT and Erk2+/
2 ES cells, a distribution of 10% undifferentiated, 70% mixed, and
20% differentiated colonies was observed (Figure 7C). This was in
contrast to Erk2-null ES cell lines were a undifferentiated colonies
increased from 10% to 30% and differentiated colonies were
reduced from 20% to 5%. These percentages returned to a WT
distribution upon transgenic expression of ERK2, indicating that
ERK2 depletion enhances self-renewal in the presence of LIF.
However, in the absence of LIF all genotypes differentiated to a
similar extent (data not shown). Taken together these data indicate
that loss of ERK2 increases the self-renewal capacity via reducing
heterogeneous expression of key pluripotency genes in the
Figure 3. Attenuation of immediate early gene (IEG) induction in ERK2-deficient ES cells. (A) Analysis of IEG induction by qRT-PCR for
Egr2, Egr1, and cFos following acute stimulation with FGF2. WT (E14Ju) and Erk2-null (D7N2) ES cells were cultured for 24 h in the presence of the
FGFR inhibitor PD173074 (PD17). The inhibitor was then washed out (0 h), and cells were stimulated with (10 ng/ml) recombinant FGF2 for 1 and 3
hours. To determine basal MEK-ERK independent expression of the genes, WT cells were stimulated with media containing both FGF2 and the MEK1
inhibitor PD0325901 (PD03) (E14Ju+PD03) (B–D) FGF2 induction results for the ERK1/2 phosphatase Dusp6 (B), the late response gene Ccnd2 (C), and
Ccnd3 (D). Error bars represent the standard deviation from the mean of biological replicates.
doi:10.1371/journal.pone.0060907.g003
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presence of LIF, but is dispensable for lineage commitment of
mouse ES cells. Our data supports a model where the total ERK
activity, and not isozyme-specific activity, is critical for the balance
between self-renewal and lineage commitment.
Discussion
Here we have determined the consequences of Erk2 deletion on
FGF-ERK signal transduction, self-renewal capacity, and lineage
specification in mouse ES cells. We have found that ES cells
compensate for the loss of ERK2 by hyper-phosphorylation of the
remaining ERK1 isozyme without an increase in Erk1 transcrip-
tion or translation. The mechanism may be through attenuation of
induced negative feedback mechanisms, such as MAPK phospha-
tases, or direct feedback within the MAPK core module. We have
found that immediate-early gene (IEG) induction is reduced in the
absence of ERK2, as well as the negative regulator Dusp6.
However, expression of a late response gene, Ccnd2, was unaffected
by the loss of ERK2, underscoring the robustness of the ERK
pathway to various perturbations [41]. Taken together this data
suggests that ERK activity is stabilized, and maintained within a
certain range, by both short (MAPK core cascade) and long
(induced phosphatases) feedback loops and indicates that targeting
these feedback loops may prove effective in modulating ERK
activity in mES cells. To address the issue of redundancy we have
shown that the early transcriptional defects in response to FGF
activation observed in Erk2-null ES cells is entirely rescued by
expression of either ERK1 or ERK2 implying that in ES cells it is
total ERK activity, rather than isozyme specificity, that is most
important for IEG induction.
In contrast to blastocyst-derived Erk22/2 ES cells of mixed
genetic background, Erk2 deletion by two rounds of homologous
recombination in ES cells of a uniform genetic background (129/
Ola) has no detectable effect on lineage specification into either
neural, endodermal, or mesodermal lineages, and in fact ERK2-
deficient ES cells appeared to differentiate towards the mesoderm
lineage more efficiently that either WT or heterozygous lines, as
judged by increased induction of Gata4 and Acta2 expression
(Figure 5B).
The lack of lineage commitment defects we observe is in
agreement with recent embryological data indicating that ERK2 is
not required for lineage specification in the embryo proper. Voisin
and colleagues used tetraploid complementation, where the extra-
embryonic tissues are wild-type, to produce grossly normal E13.5
Figure 4. Overexpression of either ERK isozyme is capable of rescuing the IEG induction phenotype of Erk22/2 ES cells. (A) Western
blot analysis of Erk2-null ES cells expressing exogenous 3X-FLAG-tagged ERK1 or ERK2. ES cells were cultured for 24 h in the presence of the FGF
receptor inhibitor PD173074 (PD17) before wash out and stimulation with recombinant FGF2 (10 ng/ml) for 5–120 min. *3X-FLAG-ERK1 migrates
slower than endogenous ERK1. **3X-FLAG-ERK2 co-migrates with ERK1. (B) qRT-PCR analysis of IEG induction following acute stimulation with
recombinant FGF2 (10 ng/ml) in WT, Erk2-null, and Erk2-null ES cells rescued with either an Erk1 or Erk2 expression construct. As for the western blot
analysis, cells were cultured for 24 h in PD17, followed by wash-out and stimulation with FGF2 for 1 h and 3 h. Robust FGF-mediated induction of
Egr2, Egr1, and cFos was restored in Erk22/2 ES cells by either ERK1 or ERK2 overexpression. (C) Western blot analysis of lysates from wild-type (E14Ju),
Erk2-null, and ERK2-rescued Erk2-null ES cells for b-catenin, pSTAT3, pAKT, and pSMAD2. No significant differences were observed in these signaling
molecules. OCT4 and GAPDH were used as loading controls.
doi:10.1371/journal.pone.0060907.g004
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Erk22/2 embryos [42]. As reported previously, the early
phenotype of Erk2-null embryos was due to cell autonomous
defects in the trophoblast lineage [23], and that the reported lack
in mesoderm induction [24], is likely a secondary defect due to a
lack of inductive signals from a defective extraembryonic
ectoderm.
Elevated expression of key pluripotency-associated genes, Nanog,
Tbx3, and Klf4 was detected in Erk2-null ES cells when compared
to WT or ERK2-rescued cells. The Nanog-GFP reporter and
Tcfcp2l1-Venus reporter on the Erk2-null background suggests this
increase in expression is probably due to reduced heterogeneity in
ES cell cultures. Undifferentiated Nanog-GFP-low ES cells are
more prone to differentiate than Nanog-GFP-high ES cells [36],
and increased self-renewal activity of Erk2-null ES cells in stringent
clonal assays is consistent with their reduced heterogeneity. Recent
work has shown that ERK activity in ES cells increases the
heterogeneous expression of the primitive endoderm marker, Hex,
and epiblast marker, Tcf15 [43,44]. These results suggest that
lowering the total active ERK pool in ES cells reduces fluctuation
of lineage-priming genes and parts of the pluripotency transcrip-
tional network, consistent with observations that chemical
inhibition of the MEK-ERK pathway promotes self-renewal and
inhibits lineage commitment [5,45]. The increase in Nanog and
Tbx3 expression observed in Erk22/2 ES cells may contribute to
the enhanced performance in clonal assays, since over-expression
of either gene strongly promotes the self-renewal capacity of ES
cells [11,40]. In summary, this work reveals that mouse ES cells
can cope with the removal of ERK2 partially by up-regulating the
activity of ERK1. This apparent functional redundancy between
the ERK enzymes has been clearly shown in embryonic
fibroblasts, where Erk12/2;Erk22/2 cells rapidly undergo senes-
cence [42]. The complete genetic removal of both Erk1 and Erk2
from ES cells will be necessary to determine if naı¨ve mouse
pluripotent stem cells require ERK enzymes for cell survival, self-
renewal, and to efficiently exit self-renewal to generate committed
lineages.
Materials and Methods
Targeting Vectors and Expression Constructs
Erk2 targeting vectors were constructed with Erk2 homology
arms kindly provided by S. Meloche and M. Saba-El-Leil (30).
Homology arms were digested with BglII to remove a 2.5 kb
fragment flanking exon 3. The vector backbone, containing 4.8 kb
59 homology and 2.8 kb 39 homology, was then ligated to a
BamHI fragment containing the floxed CMV-Hph-TK cassette.
To this a diphtheria toxin A cassette was added outside of the
homology arms as a HincII fragment. The second targeting
construct was generated by replacing the CMV-Hph-TK cassette
with a BamHI fragment containing a mPGK-Neor cassette. ERK1
and ERK2 expression constructs were generated by amplifying
Erk1 and Erk2 coding regions from E14Tg2a ES cell cDNA with
primers containing NotI and BamHI sites. The resulting PCR
fragments were digest and ligated in-frame with the 3xFLAG
Figure 5. Germ layer differentiation of ES cells is ERK2 independent. (A) Phase contrast images of embryoid bodies (EBs) at 12 days of
differentiation, arrow indicate presumptive cysts. (B) Time-course analysis of the progression of EB differentiation, showing similar differentiation
kinetics in WT (E14Ju), heterozygous (D2) and homozygous (D7N2 and D2N4) Erk2 as shown by markers of pluripotency (Oct4, Nanog), mesoderm
(Acta2, T), and endoderm (Gata4, Foxa2). Error bars represent the standard deviation from the mean of technical replicates.
doi:10.1371/journal.pone.0060907.g005
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epitope contained in a pCAG-driven expression vector with
puromycin-resistance [46]. The Tcfcp2l1-Venus reporter construct
was constructed as follows. An 8.5 kb SpeI fragment was taken
from a BAC clone (bMQ332b16) which contained a putative
promoter region, exon 1, and most of intron 1 of the Tcfcp2l1 gene.
This was cloned upstream of an adenovirus splice acceptor (SA)
and an internal ribosome entry site (IRES) from the gene-trap
vector pGT1V3 which contained a Venus expression cassette [47].
A PEST sequence was added to the C-terminal of Venus to
decrease its stability [48] and increase the sensitivity of the
promoter. A second IRES from the encephalomyocarditis virus
(ECMV) [49] was added to link expression of the puromycin N-
acetyl-transferase (PAC) gene for selection of Venus expressing
clones (Figure S4A). Vector sequence is available upon request.
ES Cell Culture and Gene Targeting
All ES cell lines were maintained in complete ES cell medium:
GMEM (Sigma, G5154) supplemented with 10% FBS (Invitro-
gen), 100 mM 2-mercaptoethanol (BDH, 441413), 1xMEM non-
essential amino acids (Invitrogen, 1140-036), 2 mM L-glutamine,
1 mM sodium pyruvate (both from Invitrogen), and 1000 units/ml
LIF (made in-house) on gelatinised tissue culture flasks (Iwaki).
The FGFR and Mek1 inhibitors, PD173074 and PD0325901,
were used at 200 nM and 1 mM, respectively, and were both from
Axon Medchem. All Erk2 gene targeting was performed in E14Ju
ES cells, which is a subclone of E14Tg2a ES cells [50]. E14Ju ES
cells (106) were electroporated with linearized DNA (100 mg) using
a BioRad GenePulser (0.8 kV and 10 mF). Stable transfectants
were selected for with the appropriate antibiotic: Hygromycin
(100 mg/ml); G418 (150 mg/ml); Puromycin (1 mg/ml). ES cell
colonies were picked to 96-well plates, replica plated, and initial
screening for targeting was by qPCR of genomic DNA for exon 3
of Erk2. Exon 3 primers are forward: 59-CTAACGTTCTG-
CACCGTGAC-39 and reverse: 59-GATCACAAGTGGTGTT-
CAGCAG-39, used with Roche Universal Probe Library (UPL)
probe #97 and control primers for diploidy were for Spry1
forward: 59-CTAACGTTCTGCACCGTGAC-39 and reverse:
59-GATCACAAGTGGTGTTCAGCAG-39 used with UPL
Figure 6. ERK2 is not required for ES cells to efficiently produce neurons under defined conditions. (A) Immunocytochemistry analysis
of wild-type, Erk2+/2 and Erk22/2 cultures after 5 days of neural induction for neuronal marker bIII Tubulin immunoreactivity (red). DNA is
counterstained with DAPI in blue. (B) Gene expression analysis of cultures following 5 and 10 days of neural induction. Markers of pluripotency (Oct4,
Nanog, and Rex1) and neural tissue (NeuroD3, Ngn2, and Mash1) are shown. Error bars represent the standard deviation from the mean of biological
replicates.
doi:10.1371/journal.pone.0060907.g006
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probe #78. The EGFP-IRES-PuroR cassette was targeted to the
Nanog locus in Erk22/2 ES cells as previously described [36].
Southern Blotting
Southern blotting was performed by resolving 5 mg gDNA,
digested with KpnI alone or KpnI-PstI, by agarose gel electro-
phoresis. gDNA was stained with ethidium bromide and nicked
using a UV trans-illuminator, followed by denaturation in
500 mM NaOH, 1.5 M NaCl for 1 hour. The reaction was
stopped by incubating the gel in 500 mM Tris, 1.5 mM NaCl,
(pH 5.5) and gDNA was transferred to a nitrocellulose membrane
(Amersham) overnight by capillary action in the presence of 20X
SSC. The DNA was then cross-linked to the membrane using a
UV oven (Stratalink) and baked for 1 h at 120uC. The
hybridization probe was labelled using the MegaPrimeTM DNA
Labeling System (Amersham) according to manufacturer’s in-
structions, using [a232P] dCTP, 3000 Ci/mmol and incubated
overnight at 68uC. Following extensive washes the membrane was
exposed to X-ray film (Kodak) overnight at 280uC and
subsequently developed in an automated autoradiographic film
processor.
ES Cell Stimulation, Differentiation and Clonal Assays
For acute FGF2 simulation, ES cells were plated at 26104 cells/
cm2 in complete ES cell medium. The following day inhibitors
were added (PD173074, 100 nM or PD0325901, 1 mM, both from
Axon Medchem) and cultured for a further 24 hours. Inhibitors
were washed out with PBS (262 ml) and cells were stimulated with
complete ES cell medium supplemented with recombinant hFGF2
(10 ng/ml, NCI Frederick BRB Repository) for 5 min to 3 hours.
Serum-free neural induction was performed as described by Ying
et al. with N2B27 medium made in-house [35]. Embryoid body
differentiation was performed in hanging drops of ES cell medium
in the absence of LIF. Cells were diluted to a concentration of
3.26103 cells/ml and aliquoted in 30 ml drops. After 2 days the
aggregates were transferred to low adhesion bacterial grade
culture dishes and cultured for the indicated times. Self-renewal
capability was determined in a colony-forming assay by plating at
low density (0.26103 cells/cm2) in the presence or absence of LIF.
Colonies were allowed to form over 7 days whereupon they were
fixed, stained for alkaline phosphatase activity using the Leukocyte
Alkaline Phosphatase Assay Kit (Sigma), and classified as either (i)
undifferentiated, (ii) mixed, or (iii) differentiated.
Western Blotting
Western blotting and multi-strip blotting were performed as
described previously [18,51]. Membranes were probed with rabbit
anti-total ERK1/2 #4695 (1:1000), rabbit anti-phospho-ERK1/2
#4370 (1:2000), rabbit anti-phospho-RSK T359/S363 #9344
(1:1000), rabbit anti-total RSK #9355 (1:1000), rabbit anti-
phospho-SMAD2 #3108 (1:1000), rabbit anti-phospho-MEK1/2
#9154, mouse anti-MEK1/2 #4694 (1:1000), rabbit anti-
phospho-AKT #4060, and rabbit anti-phospho-STAT3 #9145,
all from Cell Signaling, anti-Tubulin (1:2000, Abcam), mouse anti-
GAPDH (1:35000, Sigma), mouse anti-OCT4 (1:500, SCBT), and
rabbit anti-b-Catenin (1:1000, Sigma) and detected with the
appropriate HRP conjugated secondary (Pierce) and peroxidase
activity was visualised with the SuperSignal West Pico Kit (Pierce).
Membranes were stripped with 100 mM 2-mercaptoethanol in
72.5 mM Tris (pH 7.6) at 60uC for 15 minutes, and sequentially
probed with the indicated antibodies. For quantitative western
blotting, primary antibodies were detected with secondary
antibodies conjugated to Alexa fluorophores (Molecular Probes,
1:5000) and visualized using the BioRad ChemiDoc MP system.
Images were quantified based on pixel density using the ImageJ
software package.
Quantitative Real-time Polymerase Chain Reaction (qRT-
PCR)
Total RNA was extracted using Trizol reagent (Invitrogen)
according to the manufacturer’s instructions. First-strand synthesis
was performed using M-MLV RT (Invitrogen) with 50 ng random
hexamers (Thermo Fisher) in the presence of RNase inhibitor,
RNaseOUT (Invitrogen), in a reaction volume of 20 ml. Following
first-strand synthesis the reaction mixture was diluted to 80 ml, and
2 ml was used per qPCR reaction in Probes Master Mix (Roche)
using Universal Probe Library (UPL) probes and the LightCycler
480 system (Roche). Concentrations were determined against a
standard curve and values normalized to TBP expression, as a
house-keeping gene. Primers sequences and UPL probe numbers
are available in Supporting Table S1.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde (w/v) at room
temperature for 15 minutes followed by single step permeabiliza-
tion and blocking in 0.1% Triton-X and 2% goat serum for 1
hour. Cells were incubated with anti-bIII Tubulin (TuJ1, 1:1000,
R&D Systems) overnight. Following extensive washes, secondary
antibodies conjugated to Alexa fluorophores (Molecular Probes)
were diluted 1:1000 in blocking buffer and applied for 1 hour at
room temperature. The cells were washed twice in PBS and a
third time in PBS containing DAPI (10 mg/ml) before obtaining
pictures on an Olympus IX51 inverted fluorescence microscope.
Flow Cytometry
Cells were collected by trypsinization and resuspended in PBS
supplemented with 3% FBS. Samples were analyzed using a
FACSCalibur flow cytometer (BD Biosystems) and data processed
with FlowJo (Tree Star Inc.).
Supporting Information
Figure S1 Normal ploidy of Erk2-null ES cell lines.
Metaphase spreads of four Erk2-null ES cell lines were stained with
Giemsa and chromosome counts indicated largely normal ploidy.
(TIF)
Figure S2 Embryo-derived Erk22/2 ES cell lines exhibit
an ERK2-independent block in lineage specification. (A)
Immunocytochemistry analysis of wild-type (E14Tg2a), embryo-
derived Erk22/2 (B1) ES cells, and ERK2-rescued Erk22/2 ES
cells following 7 days of neural induction for neuronal marker bIII
Tubulin. DNA is counterstained with DAPI. (B) qRT-PCR
Figure 7. ERK2 deficiency results in increased expression of pluripotency markers and self-renewal capacity. (A) Gene expression
analysis for pluripotency markers in two independent Erk22/2 ES cell clones, D7N2 and D2N4, and transgenic rescued subclones for each line, D7WT
and D2WT. Error bars represent the standard deviation from the mean of 2 independent experiments. (B) Flow cytometry analysis of Nanog-GFP
promoter activity of Erk2-null ES cells, and rescued subclones shows a shift towards lower Nanog-GFP expression in Erk2-rescued clones. (C) Clonal
analysis in +LIF conditions showing enhanced self-renewal capacity of Erk2-null ES cells. Error bars represent the standard deviation from the mean of
biological replicates.
doi:10.1371/journal.pone.0060907.g007
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analysis of markers of pluripotency (Oct4), and neural tissue (Nestin,
bIII Tubulin, also known as Tubb3). (C) Western blot analysis of
E14Tg2a and Erk22/2 +3X-FLAG-ERK2 showing phosphoryla-
tion of exogenously expressed ERK2. (D) qRT-PCR analysis of
FGF2-mediated induction of Egr1 in E14Tg2a, embryo-derived
Erk22/2 ES cells, and ERK2-rescued Erk22/2 ES cells.
Transgenic add-back of ERK2 efficiently rescues normal Egr1
expression to Erk22/2 ES cells in three independent clones. (E)
qRT-PCR analysis of embryoid bodies at 6 days of differentiation
for markers of pluripotency (Nanog and Oct4), mesoderm (Pdgfra),
and endoderm (Gata6).
(TIF)
Figure S3 Nanog-GFP targeting. (A) Schematic depicting
Nanog targeting strategy. Black bars denote the position of the 59
external probe used for Southern analysis. (B) Southern blot
analysis of SexAI-digested genomic DNA showing correct
targeting in 9 of 10 clones tested. D2TNG and D7TNG clones
were derived from D2N4 and D7N2 Erk2-null lines, respectively.
(TIF)
Figure S4 Tcfcp2l1-Venus reporter shows increased
expression in Erk22/2 ES cells. (A) Schematic (not to scale)
depicting the final Tcfcp2l1-Venus reporter construct. An 8.5 kb
fragment of the mouse Tcfcp2l1 gene was cloned upstream of a
splice-acceptor (SA) and GTX-IRES (IRES1), followed by a
destabilized Venus protein (Venus-PEST), an ECMV-IRES
(IRES2), a puromycin-resistance gene (PAC), and a polyadenyl-
ation signal (pA). (B) FACS analysis of Erk22/2 ES cells and
ERK2-rescued Erk22/2 ES cells with the Tcfcp2l1-Venus reporter
showed that Venus expression in self-renewing conditions was
highest in the absence of ERK2. (C) Down-regulation of Venus
expression over 48 h of differentiation followed similar kinetics in
the presence or absence of ERK2.
(TIF)
Table S1 PCR primers for qRT-PCR analysis. Forward
(F) and reverse (R) primer sequences (59-39) and Roche Universal
Probe Library (UPL) probes used in qRT-PCR assays.
(PDF)
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